139 related articles for article (PubMed ID: 35258995)
1. Novel Use of Patient-Specific Covariates From Oncology Studies in the Era of Biomedical Data Science: A Review of Latest Methodologies.
Xu R; Chen G; Connor M; Murphy J
J Clin Oncol; 2022 Oct; 40(30):3546-3553. PubMed ID: 35258995
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Harnessing data science to advance radiation oncology.
Vogelius IR; Petersen J; Bentzen SM
Mol Oncol; 2020 Jul; 14(7):1514-1528. PubMed ID: 32255249
[TBL] [Abstract][Full Text] [Related]
4. How are missing data in covariates handled in observational time-to-event studies in oncology? A systematic review.
Carroll OU; Morris TP; Keogh RH
BMC Med Res Methodol; 2020 May; 20(1):134. PubMed ID: 32471366
[TBL] [Abstract][Full Text] [Related]
5. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
[No Abstract] [Full Text] [Related]
6. Prospects and challenges for clinical decision support in the era of big data.
Naqa IE; Kosorok MR; Jin J; Mierzwa M; Ten Haken RK
JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30613823
[TBL] [Abstract][Full Text] [Related]
7. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
Hu C; Steingrimsson JA
J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
[TBL] [Abstract][Full Text] [Related]
8. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
9. Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data.
Tanaka S; Tanaka S; Kawakami K
Jpn J Clin Oncol; 2015 Apr; 45(4):323-7. PubMed ID: 25589456
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness research: opportunities in surgical oncology.
Neuman HB; Greenberg CC
Semin Radiat Oncol; 2014 Jan; 24(1):43-8. PubMed ID: 24314341
[TBL] [Abstract][Full Text] [Related]
11. Qualitative studies conducted alongside randomized controlled trials in oncology: A scoping review of use and rigour of reporting.
Thiessen M; Harris D; Pinches A; Vaska M; Moules N; Raffin Bouchal S; Sinclair S
Int J Nurs Stud; 2022 Apr; 128():104174. PubMed ID: 35183865
[TBL] [Abstract][Full Text] [Related]
12. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
13. Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.
Visvanathan K; Levit LA; Raghavan D; Hudis CA; Wong S; Dueck A; Lyman GH
J Clin Oncol; 2017 Jun; 35(16):1845-1854. PubMed ID: 28358653
[TBL] [Abstract][Full Text] [Related]
14. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
Horiguchi M; Hassett MJ; Uno H
Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
[TBL] [Abstract][Full Text] [Related]
15. Patient safety classifications, taxonomies and ontologies: A systematic review on development and evaluation methodologies.
Taheri Moghadam S; Hooman N; Sheikhtaheri A
J Biomed Inform; 2022 Sep; 133():104150. PubMed ID: 35878822
[TBL] [Abstract][Full Text] [Related]
16. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
[TBL] [Abstract][Full Text] [Related]
17. Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research.
Moss HA; Melamed A; Wright JD
Gynecol Oncol; 2019 Mar; 152(3):533-539. PubMed ID: 30876500
[TBL] [Abstract][Full Text] [Related]
18. Green oncology: cultivating sustainability in medical oncology.
Palazzo S; Jirillo A; Mazurek M
J Gastrointest Cancer; 2012 Mar; 43(1):20-3. PubMed ID: 22302198
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
Cohen JW; Akshintala S; Kane E; Gnanapragasam H; Widemann BC; Steinberg SM; Shah NN
Oncologist; 2020 Jun; 25(6):532-540. PubMed ID: 31943534
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
